These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19013180)
1. CDC25A functions as a novel Ar corepressor in prostate cancer cells. Chiu YT; Han HY; Leung SC; Yuen HF; Chau CW; Guo Z; Qiu Y; Chan KW; Wang X; Wong YC; Ling MT J Mol Biol; 2009 Jan; 385(2):446-56. PubMed ID: 19013180 [TBL] [Abstract][Full Text] [Related]
2. Specificity of cyclin D1 for androgen receptor regulation. Petre-Draviam CE; Cook SL; Burd CJ; Marshall TW; Wetherill YB; Knudsen KE Cancer Res; 2003 Aug; 63(16):4903-13. PubMed ID: 12941814 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth. Mashima T; Okabe S; Seimiya H Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811 [TBL] [Abstract][Full Text] [Related]
5. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cheng H; Snoek R; Ghaidi F; Cox ME; Rennie PS Cancer Res; 2006 Nov; 66(21):10613-20. PubMed ID: 17079486 [TBL] [Abstract][Full Text] [Related]
6. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093 [TBL] [Abstract][Full Text] [Related]
7. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer. Jackson KM; Frazier MC; Harris WB Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765 [TBL] [Abstract][Full Text] [Related]
8. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related]
9. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3. Mu X; Chang C Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936 [TBL] [Abstract][Full Text] [Related]
10. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. Heemers HV; Regan KM; Dehm SM; Tindall DJ Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004 [TBL] [Abstract][Full Text] [Related]
11. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cano P; Godoy A; Escamilla R; Dhir R; Onate SA Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758 [TBL] [Abstract][Full Text] [Related]
12. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related]
13. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells. Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227 [TBL] [Abstract][Full Text] [Related]
14. Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Ma AH; Xia L; Desai SJ; Boucher DL; Guan Y; Shih HM; Shi XB; deVere White RW; Chen HW; Tepper CG; Kung HJ Cancer Res; 2006 Sep; 66(17):8439-47. PubMed ID: 16951154 [TBL] [Abstract][Full Text] [Related]
15. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate. Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cells. Azuma K; Nakashiro K; Sasaki T; Goda H; Onodera J; Tanji N; Yokoyama M; Hamakawa H Biochem Biophys Res Commun; 2010 Jan; 391(1):1075-9. PubMed ID: 20004643 [TBL] [Abstract][Full Text] [Related]
17. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and invasion in prostate cancer. Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488 [TBL] [Abstract][Full Text] [Related]
19. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells. Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]